Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AZD3480 versus donepezil monotherapy in mild to moderate Alzheimer's disease
2011-000487-10Phase 2Completed
- Sponsor
- Targacept
- Start
- Jun 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in Alzheimer's disease (AD) comparing AZD3480 monotherapy with Donepezil monotherapy (2 arms). Primary endpoint: Change in Alzheimer's Disease Assessment Scale - Cognitive. Started Jun 2011; status: completed.
02
Drugs
isproniclinedonepezil
03
Conditions
Alzheimer's disease (AD)
Beyond the preview
Go deeper on 2011-000487-10.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-000487-10.